Nov. 29, 2018—Vanderbilt's 10 newest endowed chair holders, who come from six schools and colleges across campus, were lauded for their exemplary teaching and scholarship at a Nov. 27 ceremony .
Nov. 19, 2018—Recommendations from the national report “Sexual Harassment of Women: Climate, Culture and Consequences in Academic Sciences, Engineering and Medicine” will be presented on campus Nov. 26.
Aug. 1, 2018—The Howard Hughes Medical Institute has awarded 2018 Gilliam Fellowships for Advanced Study—created to ensure that a diverse and highly trained workforce is prepared to assume leadership roles in the sciences—to three Vanderbilt University doctoral students and their advisers.
Jun. 8, 2018—Recent advances in imaging technology are enabling Vanderbilt scientists to gain unprecedented views of how molecules, cells and tissues work together, yielding radical new insights into the causes, treatment and prevention of disease.
Mar. 22, 2018—The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator.
Feb. 22, 2018—New findings suggest that oxidative stress damages mitochondrial DNA, and they link this damage to a disease state.
Aug. 30, 2017—Carlos F. Lopez, assistant professor of biochemistry and biomedical informatics, has been appointed as Vanderbilt University's liaison to Oak Ridge National Laboratory.
Feb. 9, 2017—Communication and collaboration were major themes of the inaugural Research Enterprise Forum sponsored jointly by Vanderbilt University Medical Center (VUMC) and Vanderbilt University School of Medicine (VUSM) Feb. 3 in Light Hall.
Feb. 2, 2017—Alyssa Hasty, Ph.D., professor of Molecular Physiology and Biophysics, has been named Associate Dean for Faculty Development for Basic Sciences at Vanderbilt University School of Medicine.
Jan. 19, 2017—More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.
Nov. 20, 2016—In April, when the fiscal separation of Vanderbilt University and Vanderbilt University Medical Center was completed, Larry Marnett—the University Professor of Biochemistry, Chemistry and Pharmacology and Mary Geddes Stahlman Professor of Cancer Research—assumed a new role as the School of Medicine’s first dean of basic sciences, reporting directly to the provost.
Nov. 20, 2016—Vanderbilt University School of Medicine (VUSM) has launched two new donor societies: the John E. Chapman, M.D. Society, which supports clinical programs and endowed faculty chairs, and the Discovery Circle, which supports the basic sciences.